Optimal management of luminal breast cancer: how much endocrine therapy is long enough?

por Munzone, Elisabetta, Colleoni, Marco
Publicado 2018

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer

por Montagna, Emilia, Colleoni, Marco
Publicado 2019

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

por Goldhirsch, Aron, Colleoni, Marco, Regan, Meredith
Publicado 2015

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

por Curigliano, Giuseppe, Criscitiello, Carmen, Andrè, Fabrice, Colleoni, Marco, Di Leo, Angelo
Publicado 2013

The 6th Milan Breast Cancer Conference, Milan, Italy, 16–18 June 2004

por Gennari, Roberto, Cinieri, Saverio, Colleoni, Marco, Zurrida, Stefano, Goldhirsch, Aron, Veronesi, Umberto
Publicado 2005

Sarcoidosis with bone involvement mimicking metastatic disease at (18)F-FDG PET/CT: problem solving by diffusion whole-body MRI

por Conte, Giorgio, Zugni, Fabio, Colleoni, Marco, Renne, Giuseppe, Bellomi, Massimo, Petralia, Giuseppe
Publicado 2015

Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis

por Bianco, Nadia, Palazzo, Antonella, Pagan, Eleonora, Bagnardi, Vincenzo, Milano, Monica, De Maio, Ana Paula, Colleoni, Marco
Publicado 2021

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy:...

por Dowsett, Mitch, Sestak, Ivana, Regan, Meredith M., Dodson, Andrew, Viale, Giuseppe, Thürlimann, Beat, Colleoni, Marco, Cuzick, Jack
Publicado 2018

The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer

por Zugni, Fabio, Ruju, Francesca, Pricolo, Paola, Alessi, Sarah, Iorfida, Monica, Colleoni, Marco Angelo, Bellomi, Massimo, Petralia, Giuseppe
Publicado 2018

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

por Kolberg, Hans-Christian, Colleoni, Marco, Demetriou, Georgia Savva, Santi, Patricia, Tesch, Hans, Fujiwara, Yasuhiro, Tomasevic, Zorica, Hanes, Vladimir
Publicado 2020

International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?

por Pagani, Olivia, Senkus, Elżbieta, Wood, William, Colleoni, Marco, Cufer, Tanja, Kyriakides, Stella, Costa, Alberto, Winer, Eric P., Cardoso, Fatima
Publicado 2010

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

por Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco
Publicado 2006

Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab

por Kolberg, Hans-Christian, Colleoni, Marco, Santi, Patricia, Demetriou, Georgia Savva, Segui-Palmer, Miguel Angel, Fujiwara, Yasuhiro, Hurvitz, Sara A., Hanes, Vladimir
Publicado 2019

Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive...

por Pece, Salvatore, Disalvatore, Davide, Tosoni, Daniela, Vecchi, Manuela, Confalonieri, Stefano, Bertalot, Giovanni, Viale, Giuseppe, Colleoni, Marco, Veronesi, Paolo, Galimberti, Viviana, Di Fiore, Pier Paolo
Publicado 2019

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer:...

por Ettl, Johannes, Im, Seock-Ah, Ro, Jungsil, Masuda, Norikazu, Colleoni, Marco, Schnell, Patrick, Bananis, Eustratios, Lu, Dongrui R., Cristofanilli, Massimo, Rugo, Hope S., Finn, Richard S.
Publicado 2020

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy

por Montagna, Emilia, Cancello, Giuseppe, Pagan, Eleonora, Bagnardi, Vincenzo, Munzone, Elisabetta, Dellapasqua, Silvia, Viale, Giuseppe, Mazzarol, Giovanni, Veronesi, Paolo, Galimberti, Viviana, Santomauro, Giorgia, Colleoni, Marco
Publicado 2020

Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer

por Gianni, Luca, Colleoni, Marco, Bisagni, Giancarlo, Mansutti, Mauro, Zamagni, Claudio, Del Mastro, Lucia, Zambelli, Stefania, Bianchini, Giampaolo, Frassoldati, Antonio, Maffeis, Ilaria, Valagussa, Pinuccia, Viale, Giuseppe
Publicado 2022

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

por Maisonneuve, Patrick, Disalvatore, Davide, Rotmensz, Nicole, Curigliano, Giuseppe, Colleoni, Marco, Dellapasqua, Silvia, Pruneri, Giancarlo, Mastropasqua, Mauro G, Luini, Alberto, Bassi, Fabio, Pagani, Gianmatteo, Viale, Giuseppe, Goldhirsch, Aron
Publicado 2014

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

por Sun, Zhuoxin, Niman, Samuel M., Pagani, Olivia, Partridge, Ann H., Azim, Hatem A., Peccatori, Fedro A., Ruggeri, Monica, Di Leo, Angelo, Colleoni, Marco, Gelber, Richard D., Regan, Meredith M.
Publicado 2020

Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis

por Conforti, Fabio, Pala, Laura, Sala, Isabella, Oriecuia, Chiara, De Pas, Tommaso, Specchia, Claudia, Graffeo, Rossella, Pagan, Eleonora, Queirolo, Paola, Pennacchioli, Elisabetta, Colleoni, Marco, Viale, Giuseppe, Bagnardi, Vincenzo, Gelber, Richard D
Publicado 2021